<div>REFRENCES :</div><div>[1] Tas S, Simonart T, Acta Clin Belg , Drug rash with eosinophilia
and systemic symptoms (DRESS syndrome). 1999 ;54: 197 – 200.</div><div>[2] Callot V, Roujeau JC, Bagot M, et al, Arch Dermatol ,
Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different
clinical entities. 1996 ;132: 1315 – 21.</div><div>[3] Jincy Thankachen, Vikram Agarwal, Am J Ther, Challenges in
Diagnosis, Management, and Treatment of Allopurinol-Induced DRESS
Syndrome: Case Report and Literature Review. 2015;22(3):e77-83.</div><div>[4] Y. T. Cho, C. W. Yang, and C. Y. Chu, International Journal of
Molecular Sciences, Drug reaction with eosinophilia and systemic
symptoms (DRESS): an interplay among drugs, viruses, and immune system,
2017, vol. 18.</div><div>[5] Hoetzenecker W, Nägeli M, Mehra ET, Jensen AN, Saulite I,
Schmid-Grendelmeier P, Guenova E, Cozzio A, Seminars in Immunopathology,
”Adverse cutaneous drug eruptions: current understanding”. 2016, 38 (1):
75–86.</div><div>[6] Braden GL, Warzynski MJ, Golightly M, Ballow M, Clin Immunol
Immunopathol., Cell-mediated immunity in allopurinol-induced
hypersensitivity. 1994;70:145–151.</div><div>[7] Cho YT, Yang CW, Chu CY ,International Journal of Molecular
Sciences. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS):
An Interplay among Drugs, Viruses, and Immune System. 2017, 18 (6):
1243.</div><div>[8] Bocquet H, Bagot M, Roujeau JC. Semin Cutan Med Surg,
Drug‑induced pseudolymphoma and drug hypersensitivity syndrome (Drug
Rash with Eosinophilia and Systemic Symptoms:DRESS). 1996;15:250‑7.</div><div>[9] Kardaun SH, Sidoroff A, Valeyrie Allanore L, Halevy S,
Davidovici BB, Mockenhaupt M, et al. Br J Dermatol , Variability in the
clinical pattern of cutaneous side effects of drugs with systemic
symptoms: Does a DRESS syndrome really exist? 2007;156:609 11</div><div>[10] Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. Br J Dermatol ,
The diagnosis of a DRESS syndrome has been sufficiently established on
the basis of typical clinical features and viral reactivations.
2007;156:1083‑4.</div><div>[11] Arellano F, Sacristan JA. Ann Pharmacother ,Allopurinol
hypersensitivity syndrome: a review. 1993;27:337–343.</div><div>[12] Cacoub P. Am J Med, The DRESS syndrome: a literature review.
2011;124:588–597.</div><div>[13] Jincy Thankachen, MSand Vikram Agarwal. American Journal of
Therapeutics, Challenges in Diagnosis, Management, and Treatment of
Allopurinol-Induced DRESS Syndrome: Case Report and literature Review.
2015, 22, e77–e83</div><div>[14] James J., Sammour Y. M., Virata A. R., Nordin T. A., Dumic I.
American Journal of Case Reports, Drug reaction with eosinophilia and
systemic symptoms (DRESS) syndrome secondary to furosemide: Case report
and review of literature. 2018,19, 163-170.</div><div>[15] Bachot N, Roujeau JC. Am J Clin Dermatol .Differential
diagnosis of severe cutaneous drug eruptions. 2003;4:561–572.</div><div>[16] Youssef Zemmez, Naoufal Hjira. Pan Afr Med J,
Allopurinol-induced DRESS syndrome: Drug Reaction with Eosynophilia and
Systemic Symptoms (DRESS).2018 Jun 12;30:120.</div><div>[17] Samer Hassan, Robert Wetz, Elie Zouein.Int J Gen Med,
Allopurinol causing drug rash with eosinophilia and systemic symptoms
syndrome: a challenging diagnosis. 2011; 4: 789–792.</div><div>[18] Mockenhaupt M. (2019). Drug reaction with eosinophilia and
systemic symptoms (DRESS). Up to Date. Retrieved from
https://www.uptodate.com/contents/drug-reaction-with-eosinophilia-and-systemic-s</div><div>[19] Sevinc C., Tasar T. T., Buyukkurt E. European Journal of
Geriatric Gerontology. Approach to DRESS syndrome associated with
allopurinol use in a geriatric patient. 2019, 1(3), 107-111.</div>